Asthma, Bronchial Clinical Trial
Official title:
Wheeze Detection in Children During Dynamic Bronchial Situations Measured by WIM-PC™ Recording
The WIM-PC™ device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order to evaluate the efficacy and safety of using the WIM-PC™ device for wheeze detection during dynamic bronchial situations in infants that were hospitalized as a result of asthmatic attack.
Asthma is the most common cause of hospitalization for respiratory infection in infants
under one year of age. About 1-2% of infants with bronchiolitis need to be hospitalized and
approximately 8% of these children require intensive care. Pulmonary function tests in
infants are objective, but require sedation, which is problematic in acutely ill infants.
Wheeze quantification by lung sounds analysis methods is objective, non invasive and has
been shown to correlate with clinical status in asthma and bronchiolitis. The recording
procedure is simple, requiring only the attachment of 4 ECG-size sensors to the chest wall.
A 30-second recording is often adequate, but recording time can be extended as necessary, to
obtain good quality data, where wheezes are detected and counted with high degree of
accuracy.
Karmel Sonix Ltd has developed the WIM-PC™ device, indicated for acoustic pulmonary function
measurement that quantifies the presence of wheezing. This study was designed in order to
evaluate the efficacy and safety of using the WIM-PC™ device for wheeze detection during
dynamic bronchial situations in infants that were hospitalized as a result of asthmatic
attack.
;
Observational Model: Case Control, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00825903 -
The Effects of Exercise on Physiological and Psychological Parameters in an Asthmatic Population
|
N/A | |
| Completed |
NCT00734318 -
Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma
|
Phase 3 | |
| Terminated |
NCT00385593 -
Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
|
Phase 3 | |
| Completed |
NCT00213252 -
Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma
|
Phase 2 | |
| Completed |
NCT00092092 -
Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)
|
Phase 4 | |
| Completed |
NCT00489346 -
A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)
|
Phase 3 | |
| Withdrawn |
NCT03989635 -
Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.
|
Phase 2 | |
| Withdrawn |
NCT00540839 -
A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
|
Phase 3 | |
| Recruiting |
NCT06299306 -
REACT - REAl Care for AsThma - A Disease Study to Identify Patients With Severe Uncontrolled Asthma
|
||
| Recruiting |
NCT00312312 -
Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide
|
N/A | |
| Completed |
NCT00092885 -
An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)
|
Phase 3 | |
| Not yet recruiting |
NCT06422078 -
A Non-interventional, Prospective Study With Benralizumab
|
||
| Completed |
NCT02805907 -
Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)
|
Phase 4 | |
| Not yet recruiting |
NCT00644462 -
Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording
|
N/A | |
| Completed |
NCT03839433 -
The Mannitol-Asthma-Ciclesonide-Study
|
Phase 4 | |
| Recruiting |
NCT05937334 -
The Cohort Study for Asthma in China
|
||
| Completed |
NCT03034447 -
Sleep Apnea in Asthmatic Children and Teenagers
|
N/A | |
| Completed |
NCT05270278 -
Characteristics of Type 2- High Inflammatory Endotype of Asthma Using New Biomarkers From Peripheral Blood and Exhaled Air and Its Effect on the Outcome of Therapy
|
||
| Withdrawn |
NCT00830427 -
A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects
|
Phase 2 | |
| Completed |
NCT00092105 -
Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
|
Phase 3 |